Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)

Clinical trial NCT00479388 · COMPLETED

Trial details

NCT number: NCT00479388
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia Mixed Dyslipidemia

Start date: 2007-07-01
Primary completion: 2008-07-01
Enrollment: 1216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.